A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast Cancer

Primary location

Cedars-Sinai Medical Center/ Samuel Oschin Comprehensive Cancer Institute

Los Angeles, California, United States

+3 additional locations